CIMP+ CRC is associated with distinct clinicopathological and molecular features including proximal tumor location, preponderance in elderly females, poorly differentiated and mucinous tumor histology, microsatellite instability (MSI) and frequent BRAF V600E mutation [3-10]. The gene discussed is BRAF; the disease is colorectal carcinoma.